Sanofi SA
PAR:SAN
Sanofi SA
Cost of Revenue
Sanofi SA
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sanofi SA
PAR:SAN
|
Cost of Revenue
-€21.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ipsen SA
PAR:IPN
|
Cost of Revenue
-€571.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
Vetoquinol SA
PAR:VETO
|
Cost of Revenue
-€205m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
|
Virbac SA
PAR:VIRP
|
Cost of Revenue
-€437.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
Boiron SA
PAR:BOI
|
Cost of Revenue
-€135.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Medincell SA
PAR:MEDCL
|
Cost of Revenue
-€3.4m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
See Also
What is Sanofi SA's Cost of Revenue?
Cost of Revenue
-21.5B
EUR
Based on the financial report for Mar 31, 2024, Sanofi SA's Cost of Revenue amounts to -21.5B EUR.
What is Sanofi SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
-28%
Over the last year, the Cost of Revenue growth was -28%.